Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Basic and clinical research in polyomavirus nephropathy.

Jennifer Trofe1, Jennifer Gordon, Prabir Roy-Chaudhury

  • 1Division of Transplantation, University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267-0558, USA. Jennifer.trofe@uc.edu

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|April 30, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Not all reference samples are equal in single-cell transcriptomics of human kidney tissue.

JCI insight·2026
Same author

Deep profiling of lupus nephritis kidneys reveals dynamic changes in myeloid cells associated with disease progression.

Annals of the rheumatic diseases·2026
Same author

A population-scale atlas of blood and tissue in lupus nephritis.

bioRxiv : the preprint server for biology·2026
Same author

CO-STIMULATORY BLOCKADE PREVENTS INTRAGRAFT ACCRUAL OF CLASS-SWITCHED, ACTIVATED B CELLS DESPITE FAILING TO PREVENT T-CELL MEDIATED REJECTION.

bioRxiv : the preprint server for biology·2025
Same author

Cellular and Spatial Drivers of Unresolved Injury and Functional Decline in the Human Kidney.

bioRxiv : the preprint server for biology·2025
Same author

Low prevalence of glomerulonephritis in transplanted kidneys from deceased donors with active hepatitis C virus infection.

Kidney international·2025
Same journal

Successful Anesthetic Management of Deceased Donor Liver Transplant in a Patient With Neonatal Sclerosing Cholangitis As a Result of DCDC2 (doublecortin domain-containing protein 2) Mutation: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Twenty-Year Follow-up After Combined Heart and Kidney Transplant: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Fibrin Hydrogel Containing Microvascular Fragments for Improving Subcutaneous Islet Transplants in Diabetic Rats.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Investigation of the Relationship Between Antibody-Mediated Rejection and Serum Interleukin 40 Levels in Heart Transplant Patients.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Effect of Body Mass Index on Complications and Survival After Living Donor Liver Transplantation.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same journal

Tacrolimus Levels 10 Years After Kidney Transplant and Long-Term Clinical Outcomes: A Propensity Score-Matched Analysis.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
See all related articles

Polyomavirus nephropathy (PVN) is a significant cause of kidney transplant failure, often occurring within a year post-transplant. Research focuses on identifying risk factors and improving diagnosis and treatment to enhance graft survival.

Area of Science:

  • Nephrology
  • Virology
  • Transplantation Immunology

Background:

  • Polyomavirus nephropathy (PVN) is an emerging complication in renal transplantation, leading to graft dysfunction and loss.
  • BK virus is the primary cause of PVN, affecting 1%-8% of recipients, typically within the first year.
  • Current understanding of PVN risk factors remains incomplete, likely involving complex donor and recipient interactions.

Purpose of the Study:

  • To review recent advances in understanding and managing polyomavirus nephropathy in renal transplant recipients.
  • To highlight current research directions in PVN risk factor identification, diagnosis, and treatment.
  • To discuss the impact of PVN on allograft outcomes and strategies for improvement.

Main Methods:

  • Histological assessment of renal allograft biopsy remains the gold standard for definitive PVN diagnosis.

Related Experiment Videos

  • Noninvasive urine and serum markers are being evaluated for BK virus screening and monitoring.
  • Treatment strategies primarily involve adjusting immunosuppression, with limited options for antiviral therapy.

    • Main Results:

    • PVN diagnosis relies on biopsy, but noninvasive markers show promise for screening.
    • Immunosuppression reduction is the main treatment, balanced against rejection risk.
    • No FDA-approved antiviral treatments exist; cidofovir shows efficacy but carries nephrotoxicity risks.

    Conclusions:

    • PVN is a critical challenge in renal transplantation, necessitating improved diagnostic and therapeutic approaches.
    • Ongoing research aims to identify risk factors, refine screening/monitoring, and develop effective treatments.
    • Improving PVN management is crucial for enhancing long-term allograft survival and patient outcomes.